-
1 . Periodical
Eplerenone for chronic central serous chorioretinopathy in patients with active, previously untreated disease for more than 4 months (VICI): a randomised, double-blind, placebo-controlled trial
- 저자
- by Lotery, Andrew; Sivaprasad, Sobha; O'Connell, Abby; Harris, Rosie A; Culliford, Lucy, et al.
- 소스
- The Lancet; January 2020, Vol. 395 Issue: 10220 p294-303, 10p